↓ Skip to main content

An immunological panacea for cancer-related cachexia

Overview of attention for article published in Trends in Cancer, June 2026
Altmetric Badge

Mentioned by

bluesky
1 Bluesky user
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
An immunological panacea for cancer-related cachexia
Published in
Trends in Cancer, June 2026
DOI 10.1016/j.trecan.2026.06.005
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2026.
All research outputs
#28,400,759
of 34,151,718 outputs
Outputs from Trends in Cancer
#1,001
of 1,095 outputs
Outputs of similar age
#224,547
of 340,088 outputs
Outputs of similar age from Trends in Cancer
#24
of 37 outputs
Altmetric has tracked 34,151,718 research outputs across all sources so far. This one is in the 9th percentile – i.e., 9% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,095 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.4. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,088 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.